Hyperbilirubinemia (elevated bilirubin)
Last updated: 14 September 2026
Reviewed by: Specialist doctors from the Elfcare quality team
Being told that bilirubin levels are elevated on a blood test, or noticing a mild yellowing of the skin or eyes with no explanation, can be an early sign worth investigating. So can dark urine, pale stools, or persistent itching alongside these changes. Elevated bilirubin (hyperbilirubinaemia) is one of the more informative findings a blood test can produce, because its pattern of elevation points directly to the underlying cause, which ranges from entirely benign to clinically urgent.
Bilirubin is a sensitive and specific marker of liver, biliary, and haematological health. A comprehensive blood panel that measures total, direct, and indirect bilirubin alongside liver function and haematological markers provides the complete picture needed to identify why bilirubin is elevated and what, if anything, needs to be done about it.
Book a consultation now to test your health
What is hyperbilirubinaemia?
Bilirubin is a yellow-orange pigment produced from the breakdown of haemoglobin when ageing red blood cells are recycled by the spleen and liver. It circulates in two forms that have distinct clinical significance:
Unconjugated (indirect) bilirubin is the water-insoluble form produced from haemoglobin breakdown, bound to albumin in the blood and transported to the liver for processing.
Conjugated (direct) bilirubin is the water-soluble form after liver processing (conjugation by UGT1A1 enzyme), excreted into bile and eliminated through the gut. A small amount circulates in the blood normally.
Normal total serum bilirubin is typically below 21 µmol/L. Hyperbilirubinaemia refers to bilirubin levels above the normal range. The clinical significance depends on which bilirubin fraction is elevated and the underlying cause:
Predominantly unconjugated hyperbilirubinaemia indicates either overproduction of bilirubin (haemolysis) or impaired hepatic conjugation (Gilbert syndrome, Crigler-Najjar syndrome).
Predominantly conjugated hyperbilirubinaemia indicates impaired biliary excretion from liver disease or biliary obstruction, and is always clinically significant.
Mixed hyperbilirubinaemia with both fractions elevated indicates significant hepatocellular disease.
Visible jaundice, yellowing of the skin and sclera, typically becomes apparent when total bilirubin exceeds approximately 35 to 50 µmol/L.
Symptoms of hyperbilirubinaemia
Symptoms of hyperbilirubinaemia depend on the underlying cause and the degree of bilirubin elevation:
Mild unconjugated hyperbilirubinaemia (e.g. Gilbert syndrome):
Intermittent mild scleral icterus (yellowing of the whites of the eyes)
No dark urine, no pale stools, no itching
No abdominal pain or systemic symptoms
Haemolytic hyperbilirubinaemia:
Jaundice, fatigue, and pallor from anaemia
Occurrence of dark urine from haemoglobin breakdown products
Splenomegaly from increased red cell destruction
Hepatocellular hyperbilirubinaemia (liver disease):
Jaundice with fatigue, nausea, and abdominal discomfort
Occurrence of dark urine and pale stools in more significant disease
Other signs of liver dysfunction including easy bruising and ascites in advanced cases
Cholestatic hyperbilirubinaemia (biliary obstruction):
Progressive jaundice, often painless when caused by malignancy
Intense pruritus from bile salt deposition in the skin
Occurrence of dark urine and pale or pale stools
Right upper abdominal pain when caused by gallstones
Fever when biliary obstruction is complicated by cholangitis
Important: Fever, jaundice, and abdominal pain together may indicate ascending cholangitis, a serious biliary infection requiring immediate medical attention.
What causes hyperbilirubinaemia?
High bilirubin is grouped by the type of waste building up in your blood:
Unconjugated buildup (before the liver)
Gilbert syndrome: a common, harmless genetic trait where the liver naturally processes bilirubin slowly. It requires no treatment.
Hemolytic anemia & blood conditions: diseases like sickle cell, thalassemia, or G6PD deficiency cause red blood cells to burst prematurely, flooding the body with excess pigment.
Crigler-najjar syndrome: a rare, severe genetic condition where the liver entirely lacks the ability to process bilirubin.
Conjugated buildup (after the liver)
Liver dysfunction: conditions like hepatitis, alcohol damage, fatty liver disease, or medication injuries prevent the liver from flushing out processed waste.
Bile duct blockages: physical blocks like gallstones, pancreatic tumors, or strictures pinch the drainage tubes, backing waste up into the blood.
Dubin-johnson & rotor syndromes: rare, harmless genetic conditions where the liver processes the waste normally but struggles to pass it into the bile ducts.
Mixed buildup
Advanced liver disease: severe issues like liver failure or cirrhosis cause a combined backup because the liver can neither process nor excrete the waste properly.
How is hyperbilirubinaemia detected?
Hyperbilirubinaemia is detected through blood testing, with abdominal MRI providing structural assessment of the liver and biliary system when indicated.
Blood tests Elfcare's panel includes bilirubin and the key related markers for establishing the underlying cause:
Bilirubin: measures total and direct bilirubin levels and helps classify the pattern of elevation.
ALT and AST: elevate during active liver cell irritation or damage.
ALP and GGT: are often elevated in cholestatic liver disease and biliary obstruction.
Albumin: low levels signal advanced, long-term liver damage.
Haemoglobin and reticulocytes: check for anemia or bursting red blood cells.
CRP and full blood count: flag active infections or body-wide inflammation.
Abdominal MRI Elfcare's full body MRI images the liver, bile ducts, gallbladder, and pancreas directly as part of the standard abdominal sequence. When conjugated hyperbilirubinaemia suggests biliary obstruction, MRI identifies the level and likely cause of obstruction, including gallstones, bile duct masses, and pancreatic head tumours. It also assesses liver parenchymal changes from hepatocellular disease and identifies complications including biliary dilatation and ascites.
Why early detection matters
The clinical significance of hyperbilirubinaemia ranges from the entirely benign, as in Gilbert syndrome requiring nothing more than reassurance, to the clinically urgent, as in malignant biliary obstruction or acute liver failure requiring immediate specialist care. The pattern of bilirubin elevation and accompanying blood markers determines which scenario applies, and identifying this pattern early prevents unnecessary anxiety for benign causes and prevents dangerous diagnostic delay for serious ones. Conjugated hyperbilirubinaemia caused by biliary obstruction can occasionally be an early sign of pancreatic or biliary disease, including cancer. Recognising this pattern early helps ensure timely imaging and specialist assessment when needed.
How Elfcare can help
Elfcare's blood panel includes total bilirubin, direct bilirubin, a full liver function profile, and haematological markers, providing the complete pattern of results needed to classify hyperbilirubinaemia, identify its most likely cause, and determine the urgency of further investigation.
Our abdominal MRI images the liver and biliary system directly, identifying structural causes of conjugated hyperbilirubinaemia including biliary obstruction that require specialist assessment.
The combination of a comprehensive bilirubin fractionation with liver enzymes, haematological markers, and structural MRI imaging provides the most complete assessment of hyperbilirubinaemia available in a preventive health check.
If our blood tests or MRI identify significant hyperbilirubinaemia or a structural cause requiring further assessment, we take care of further diagnostics or refer you to the appropriate specialist.
Summary
Hyperbilirubinaemia is elevated bilirubin in the blood, with clinical significance determined entirely by which fraction is elevated and the underlying cause. Unconjugated elevation most commonly reflects Gilbert syndrome or haemolysis. Conjugated elevation always indicates liver disease or biliary obstruction requiring investigation. Mixed elevation suggests significant hepatocellular disease. Elfcare's blood panel measures total and direct bilirubin alongside liver enzymes and haematological markers, providing the complete pattern for accurate classification, while our abdominal MRI identifies structural biliary and hepatic causes. Early identification of the cause of hyperbilirubinaemia, distinguishing the benign from the serious, is central to protecting long-term health of the liver and biliary system.
Last updated: 14 September 2026
Reviewed by: Specialist doctors from the Elfcare quality team
FAQ
-
Hyperbilirubinaemia is a persistently elevated total serum bilirubin above 21 µmol/L, causing jaundice when it exceeds approximately 35 to 50 µmol/L. It is classified by the fraction elevated: predominantly unconjugated (from haemolysis or impaired conjugation), predominantly conjugated (from liver disease or biliary obstruction), or mixed (from significant hepatocellular disease). The cause determines clinical significance, ranging from entirely benign to requiring urgent specialist care.
-
Mild unconjugated hyperbilirubinaemia from Gilbert syndrome causes intermittent mild scleral icterus without other symptoms. Haemolytic hyperbilirubinaemia causes jaundice with anaemia and fatigue. Conjugated hyperbilirubinaemia from biliary obstruction causes progressive jaundice, intense itching, dark urine, and pale stools, with fever indicating a serious biliary infection requiring immediate attention.
-
Unconjugated elevation is most commonly caused by Gilbert syndrome or haemolytic anaemia. Conjugated elevation is caused by intrahepatic cholestasis from liver disease or extrahepatic biliary obstruction from gallstones, pancreatic tumours, or bile duct cancer. Mixed elevation occurs in significant hepatocellular disease including acute liver failure, cirrhosis, and severe hepatitis.
-
A blood test measuring total and direct bilirubin alongside ALT, AST, ALP, GGT, albumin, and haematological markers establishes the cause in most cases. Abdominal MRI identifies structural causes of conjugated hyperbilirubinaemia including biliary obstruction, liver masses, and pancreatic head tumours.
-
Yes. Elfcare's blood panel includes total bilirubin, direct bilirubin, a full liver function profile, and haematological markers. Our abdominal MRI images the liver, bile ducts, gallbladder, and pancreas directly. If significant hyperbilirubinaemia or a structural cause is identified, we take care of further diagnostics or refer you to the appropriate specialist.
-
Treatment depends entirely on the underlying cause. Gilbert syndrome requires no treatment. Haemolytic anaemia is treated according to its specific cause, including corticosteroids for autoimmune haemolysis and specific treatments for hereditary conditions. Biliary obstruction from gallstones is treated endoscopically with ERCP. Malignant biliary obstruction is managed with stenting and systemic treatment of the primary cancer. Hepatocellular causes are treated by addressing the underlying liver condition. Identifying the cause accurately and promptly is the most important step in determining the appropriate management.